6 October 2020

Kamco Invest acts as exclusive sell-side advisor to a healthcare group in Egypt

Al Tayseer Group transaction
Kamco Invest acted as the exclusive sell-side advisor to Al-Tayseer Healthcare Group (“THG”) in Egypt in the sale of a minority stake to the private equity fund of Ezdehar Management (Ezdehar), an Egypt-based private equity firm.

The transaction was successfully executed in September 2020 through the Ezdehar Egypt Mid-Cap Fund to support THG’s in consolidating its position as the largest healthcare provider in Egypt’s underserved Delta region. The fund comprises contributions from several international institutions; foremost among them are the European Bank for Reconstruction and Development (EBRD), the European Investment Bank (EIB), UK’s CDC Group, and the Dutch Entrepreneurial Development Bank FMO.


Over the past five years, THG witnessed strong growth supported by the expansion of its flagship hospital, Al-Tayseer International Hospital located in Zagazig, Egypt. THG also pursued a series of investment activities, including an 80% acquisition in Hassab Labs in 2019, where Kamco Invest took on the role of exclusive buy-side advisor.


Abdullah AlSharekh, Managing Director of Markets and Investment Banking at Kamco Invest, said, “We are proud to once again successfully assist Al-Tayseer Healthcare Group in concluding a milestone transaction that will diversify its shareholder base and aid the organization in solidifying its role as a leading hospital group in Egypt’s Delta region. THG’s witnessed growth rate throughout the past period affirms the investors’ confidence in the company and its ability to achieve exceptional performance levels in the future.”


Dr. Mohamed Gazar, co-founder and Chief Executive Officer (CEO) of THG, said: “We are proud that Ezdehar joined hands with us and contributed in THG’s journey of growth, which comes as an affirmation of the investors’ confidence in the company's performance in the past period, along with their belief in its ability to achieve success in the upcoming period.”


Kamco Invest has acted as investment banker to deals exceeding USD23bn since its inception in equity capital markets, debt capital markets and mergers & acquisitions. It has advised M&A mandates worth more than USD5.5bn in various markets and industries including healthcare, financial services and industrial, amongst others. More recently, Kamco Invest was awarded the ‘Best M&A Bank in the Middle East – 2020’ award from the highly accredited and internationally renowned Global Finance.


It is worth mentioning that Al-Tayseer Healthcare Group is an Egyptian healthcare investment platform started in the nineties with the aim of enhancing the quality and accessibility of health care in Egypt. The Group’s vision is to create the leading integrated healthcare group in North Egypt, operating across healthcare segments (Inpatient, outpatient, diagnostics, and homecare), providing high quality healthcare at affordable prices.


AlSharekh concluded, “With extensive track record, regional reach and multi sectorial expertise coupled with our commitment to delivering our services at the highest standards to achieve the strategic objectives of our clients, Kamco Invest is well positioned to successfully work on regional M&A mandates as well as debt and equity capital market transactions.”

Media Contacts

If you need any additional information or have some inquires, please visit our Media Contacts page.